Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eli Lilly | LLY | Nov 8, 2024 | 831.54 | +4.27 |
Elicio Therapeutics | ELTX | Nov 8, 2024 | 5.08 | +10.20 |
Eliem Therapeutics | ELYM | Nov 8, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC | Nov 8, 2024 | 12.43 | 0.00 |
Ellington Financial | EFC-B | Nov 8, 2024 | 22.55 | 0.00 |
Ellington Financial A Pref | EFC-A | Nov 8, 2024 | 25.33 | 0.00 |
Ellington Financial D Pref | EFC-D | Nov 8, 2024 | 22.47 | 0.00 |
Ellington Financial E Pref | EFC-E | Nov 8, 2024 | 25.41 | 0.00 |
Ellington Financial Pref | EFC-C | Nov 8, 2024 | 25.39 | 0.00 |
Ellington Residential Mortgage REIT | EARN | Nov 8, 2024 | 6.62 | +3.28 |
Ellomay Capital | ELLO | Nov 8, 2024 | 13.44 | 0.00 |
Ellsworth Growth | ECF | Nov 8, 2024 | 9.55 | 0.00 |
Ellsworth Growth A | ECF-A | Nov 8, 2024 | 23.77 | 0.00 |
Elme Communities | ELME | Nov 8, 2024 | 17.26 | 0.00 |
Eltek | ELTK | Nov 8, 2024 | 10.72 | -2.55 |
Elutia | ELUT | Nov 8, 2024 | 3.80 | +0.26 |
Embecta | EMBC | Nov 8, 2024 | 15.54 | +1.64 |
Embotelladora Andina ADR | AKO-B | Nov 8, 2024 | 17.95 | 0.00 |
Embotelladora Andina ADR | AKO-A | Nov 8, 2024 | 13.66 | 0.00 |
Embrace Change Acquisition | EMCG | Nov 8, 2024 | 11.60 | 0.00 |
Embrace Change Acquisition Unit | EMCGU | Nov 8, 2024 | 11.70 | 0.00 |
Embraer ADR | ERJ | Nov 8, 2024 | 35.18 | 0.00 |
EMCOR Group | EME | Nov 8, 2024 | 504.35 | 0.00 |
Emcore | EMKR | Nov 8, 2024 | 3.05 | +28.69 |
Emerald Holding | EEX | Nov 8, 2024 | 4.63 | 0.00 |
Emeren ADR | SOL | Nov 8, 2024 | 2.18 | 0.00 |
Emergent BioSolutions | EBS | Nov 8, 2024 | 11.00 | 0.00 |
Emerson Electric | EMR | Nov 8, 2024 | 127.26 | +0.06 |
Emerson Radio | MSN | Nov 8, 2024 | 0.52 | 0.00 |
Empire Petroleum | EP | Nov 8, 2024 | 6.07 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.